Oruka Therapeutics, Inc.
🇺🇸United States
Clinical Trials
3
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Not Applicable
1 (33.3%)ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis
Not Applicable
Recruiting
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: ORKA-001 Induction DoseDrug: ORKA-001 Maintenance DoseOther: Placebo
- First Posted Date
- 2025-07-29
- Last Posted Date
- 2025-07-29
- Lead Sponsor
- Oruka Therapeutics, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT07090330
- Locations
- 🇨🇦
Oruka Therapeutics Investigative Site, Peterborough, Ontario, Canada
ORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single Dose
- First Posted Date
- 2025-04-25
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Oruka Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06944379
- Locations
- 🇳🇿
Oruka Therapeutics Investigative Site, Christchurch, New Zealand
ORKA-001 in Healthy Volunteers
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Oruka Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06698939
- Locations
- 🇳🇿
Oruka Therapeutics Investigative Site, Christchurch, New Zealand
News
No news found